Key facts
- Chinese medical device manufacturers are increasing their presence in Europe.
- An anti-corruption campaign in China is creating challenges for domestic businesses.
- Companies are seeking international markets to diversify and mitigate risks.
- Europe represents a key target market for this expansion.
Chinese medical device manufacturers are actively pursuing expansion into European markets, a strategic move driven by a significant anti-corruption campaign that is tightening regulatory oversight and impacting business operations within China. This domestic squeeze is prompting companies to look abroad for growth and to diversify their revenue streams, thereby reducing their reliance on the Chinese market and mitigating associated risks.
Europe has emerged as a primary target for this international push, offering a large consumer base and a more stable regulatory environment compared to the current domestic climate. The companies aim to establish a stronger foothold in these new markets, potentially through increased sales, partnerships, or even acquisitions, as they navigate the challenges posed by the ongoing crackdown at home.